首页> 外国专利> METHOD FOR STRATIFYING THE RISK OF BK VIRUS NEPHROPATHY AFTER A KIDNEY TRANSPLANT

METHOD FOR STRATIFYING THE RISK OF BK VIRUS NEPHROPATHY AFTER A KIDNEY TRANSPLANT

机译:肾脏移植后消除BK病毒性肾病风险的方法

摘要

The present application describes and claims a novel method for identifying and stratifying the risk of developing a BK virus nephropathy ("Nx BK-v" below) in patients having undergone a kidney transplant. This method uses an index combining at least three bio-markers: i) the intensity of the anti-BK-v memory T lymphocyte response (memory T lymphocytes which are specific to BK-v, hereinafter "LTm anti-BK-v"), ii) the number of occurrences of incompatibility in the HLA alleles of class I and class II between the donor and the recipient of the graft, taking into account iii) the viral charge of the BK-v virus in the whole blood of the patient. The present method allows a very precise evaluation of the risk of developing an Nx BK-v during the months following the test with the aim of optimising the immuno-suppressive treatment in order to better preserve the transplanted kidney.
机译:本申请描述并要求保护一种新方法,该方法用于鉴定和分层在经历了肾脏移植的患者中发生BK病毒性肾病(以下称为“ Nx BK-v”)的风险。该方法使用结合至少三种生物标志物的指数:i)抗BK-v记忆T淋巴细胞反应的强度(对BK-v特异的记忆T淋巴细胞,以下简称“ LTm抗BK-v”) ,ii)考虑到iii)患者全血中BK-v病毒的病毒载量,在移植物的供体和受体之间在I类和II类HLA等位基因中不相容的发生次数。本方法允许在测试后的几个月中非常精确地评估开发Nx BK-v的风险,目的是优化免疫抑制治疗以更好地保存移植的肾脏。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号